We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

QLT Unit Pays $112.5M To Resolve Drug Dispute

Law360 (February 9, 2007, 12:00 AM EST) -- A U.S. unit of Canada’s generic drug maker QLT Inc. has agreed to shell out $112.5 million to settle a patent infringement lawsuit over its prostate cancer drug Eligard.

To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.